CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...
The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
Dermatologist Dr. Nancy Samolitis breaks down how to treat dark spots, melasma, and sun damage on the 'Live + Well' podcast.
Final results from the pivotal CheckMate 238 trial showed adjuvant nivolumab continues to significantly improve RFS compared with ipilimumab for patients with advanced melanoma, according to data ...
If you’re brand-new to retinol, dermatologist Dr. Karan Lal advises starting with a retinol (the weakest form of a retinoid) and using it for about six months to see how your skin adapts before moving ...
Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback